-+ 0.00%
-+ 0.00%
-+ 0.00%

Sino Biopharma wins FDA clearance to start trial of CPX301 GLP-1 weight-loss microneedle patch

PUBT·08/25/2026 04:11:09
Listen to the news
Sino Biopharma wins FDA clearance to start trial of CPX301 GLP-1 weight-loss microneedle patch
  • Sino Biopharmaceutical’s GLP-1 dissolving microneedle patch CPX301 received US FDA clearance to begin clinical trials for weight management.
  • The candidate was developed by its Beijing Tide unit using a dissolving microneedle platform aimed at replacing injections with a short-wear patch.
  • The company is also preparing a China clinical filing for CPX301.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content used to generate this news brief on August 24, 2026, and is solely responsible for the information contained therein.